Jumanji's dominant reign at the box office comes to an end as the third and final Maze Runner movie, The Death Cure, has made $8.4 million so far since its Friday debut and is projected to take in $24 million by weekend's end, writes The Hollywood Reporter. Right now, Jumanji is bringing up the close rear with $3.7 million, based on Box Office Mojo estimates of Friday ticket sales. Quite an impressive feat, as it's been in theaters for over a month now and led the box office for the last three weeks in a row. Meanwhile, Scott Cooper's post-Civil War western, Hostiles, is in third with $3.4 million.
The Death Cure was directed by Wes Ball (who helmed the first two Maze Runner films) and closes out the dystopian triology based on James Dashner's series of YA books, which actually include six novels to date. In the third film, Thomas (Dylan O'Brien) attempts to save his friends in the Last City while being chased by Janson (Game of Thrones' Aidan Gillen). While slated for a February 2017 release, the project had to halt production after O'Brien was seriously injured on set.
Despite leading the box office, The Death Cure is the worst-reviewed Maze Runner on Rotten Tomatoes, with a 44% and a consensus of: "Maze Runner: The Death Cure may offer closure to fans of the franchise, but for anyone who hasn't already been hooked, this bloated final installment is best left unseen." The first movie, simply titled The Maze Runner, got a 65% in 2014, while The Scorch Trials received a 46% in 2015. In theory, the film's weekend success thus far may be attributed to longtime fans of the books and adaptations who want to see how the trilogy ends.